Hunan Jiudian Pharmaceutical Co Ltd Net Asset Quality Index
Hunan Jiudian Pharmaceutical Co Ltd net asset quality index. Hunan Jiudian Pharmaceutical Co Ltd (300705) has a Net Asset Quality Index of 65.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.18 Billion minus total liabilities of CN¥1.43 Billion yields net assets of CN¥2.75 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Hunan Jiudian Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
Net asset quality index of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025. This chart shows how Hunan Jiudian Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 65.8%, representing net assets of CN¥2.75 Billion against total assets of CN¥4.18 Billion CNY. See net assets of Hunan Jiudian Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
Hunan Jiudian Pharmaceutical Co Ltd Net Asset Quality Index by Year (2013–2025)
Hunan Jiudian Pharmaceutical Co Ltd net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hunan Jiudian Pharmaceutical Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 69.3% | CN¥2.79 Billion | CN¥4.02 Billion | CN¥1.23 Billion | ▼ -5.6 pp |
| 2024 | 74.9% | CN¥2.53 Billion | CN¥3.37 Billion | CN¥846.40 Million | ▲ +6.2 pp |
| 2023 | 68.7% | CN¥1.97 Billion | CN¥2.87 Billion | CN¥897.93 Million | ▲ +1.2 pp |
| 2022 | 67.5% | CN¥1.55 Billion | CN¥2.30 Billion | CN¥747.05 Million | ▲ +4.5 pp |
| 2021 | 63.0% | CN¥1.10 Billion | CN¥1.75 Billion | CN¥645.90 Million | ▼ -10.9 pp |
| 2020 | 73.9% | CN¥835.68 Million | CN¥1.13 Billion | CN¥295.04 Million | ▲ +2.8 pp |
| 2019 | 71.1% | CN¥761.87 Million | CN¥1.07 Billion | CN¥310.23 Million | ▼ -5.1 pp |
| 2018 | 76.1% | CN¥718.16 Million | CN¥943.21 Million | CN¥225.05 Million | ▼ -9.7 pp |
| 2017 | 85.8% | CN¥660.26 Million | CN¥769.20 Million | CN¥108.95 Million | ▲ +4.4 pp |
| 2016 | 81.5% | CN¥323.43 Million | CN¥397.03 Million | CN¥73.60 Million | ▲ +1.5 pp |
| 2015 | 80.0% | CN¥254.51 Million | CN¥318.32 Million | CN¥63.81 Million | ▲ +1.8 pp |
| 2014 | 78.1% | CN¥209.87 Million | CN¥268.57 Million | CN¥58.71 Million | ▲ +8.4 pp |
| 2013 | 69.7% | CN¥175.85 Million | CN¥252.15 Million | CN¥76.30 Million | — |